Research ExplorerPublicationsSomatic symptom disorder: a scoping review on the empirical ...

Somatic symptom disorder: a scoping review on the empirical evidence of a new diagnosis

Standard

Somatic symptom disorder: a scoping review on the empirical evidence of a new diagnosis. / Löwe, Bernd; Levenson, James; Depping, Miriam; Hüsing, Paul; Kohlmann, Sebastian; Lehmann, Marco; Shedden-Mora, Meike; Toussaint, Anne; Uhlenbusch, Natalie; Weigel, Angelika.

In: PSYCHOL MED, Vol. 52, No. 4, 03.2022, p. 632–648.

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

Harvard

Löwe, B, Levenson, J, Depping, M, Hüsing, P, Kohlmann, S, Lehmann, M, Shedden-Mora, M, Toussaint, A, Uhlenbusch, N & Weigel, A 2022, 'Somatic symptom disorder: a scoping review on the empirical evidence of a new diagnosis', PSYCHOL MED, vol. 52, no. 4, pp. 632–648. https://doi.org/10.1017/S0033291721004177

APA

Löwe, B., Levenson, J., Depping, M., Hüsing, P., Kohlmann, S., Lehmann, M., Shedden-Mora, M., Toussaint, A., Uhlenbusch, N., & Weigel, A. (2022). Somatic symptom disorder: a scoping review on the empirical evidence of a new diagnosis. PSYCHOL MED, 52(4), 632–648. https://doi.org/10.1017/S0033291721004177

Vancouver

Löwe B, Levenson J, Depping M, Hüsing P, Kohlmann S, Lehmann M et al. Somatic symptom disorder: a scoping review on the empirical evidence of a new diagnosis. PSYCHOL MED. 2022 Mar;52(4):632–648. https://doi.org/10.1017/S0033291721004177

Bibtex

@article{584e2036724740c881f7a5644ed4978c,
title = "Somatic symptom disorder: a scoping review on the empirical evidence of a new diagnosis",
abstract = "BACKGROUND: In 2013, the diagnosis of somatic symptom disorder (SSD) was introduced into the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). This review aims to comprehensively synthesize contemporary evidence related to SSD.METHODS: A scoping review was conducted using PubMed, PsycINFO, and Cochrane Library. The main inclusion criteria were SSD and publication in the English language between 01/2009 and 05/2020. Systematic search terms also included subheadings for the DSM-5 text sections; i.e., diagnostic features, prevalence, development and course, risk and prognostic factors, culture, gender, suicide risk, functional consequences, differential diagnosis, and comorbidity.RESULTS: Eight hundred and eighty-two articles were identified, of which 59 full texts were included for analysis. Empirical evidence supports the reliability, validity, and clinical utility of SSD diagnostic criteria, but the further specification of the psychological SSD B-criteria criteria seems necessary. General population studies using self-report questionnaires reported mean frequencies for SSD of 12.9% [95% confidence interval (CI) 12.5-13.3%], while prevalence studies based on criterion standard interviews are lacking. SSD was associated with increased functional impairment, decreased quality of life, and high comorbidity with anxiety and depressive disorders. Relevant research gaps remain regarding developmental aspects, risk and prognostic factors, suicide risk as well as culture- and gender-associated issues.CONCLUSIONS: Strengths of the SSD diagnosis are its good reliability, validity, and clinical utility, which substantially improved on its predecessors. SSD characterizes a specific patient population that is significantly impaired both physically and psychologically. However, substantial research gaps exist, e.g., regarding SSD prevalence assessed with criterion standard diagnostic interviews.",
author = "Bernd L{\"o}we and James Levenson and Miriam Depping and Paul H{\"u}sing and Sebastian Kohlmann and Marco Lehmann and Meike Shedden-Mora and Anne Toussaint and Natalie Uhlenbusch and Angelika Weigel",
year = "2022",
month = mar,
doi = "10.1017/S0033291721004177",
language = "English",
volume = "52",
pages = "632–648",
journal = "PSYCHOL MED",
issn = "0033-2917",
publisher = "Cambridge University Press",
number = "4",

}

RIS

TY - JOUR

T1 - Somatic symptom disorder: a scoping review on the empirical evidence of a new diagnosis

AU - Löwe, Bernd

AU - Levenson, James

AU - Depping, Miriam

AU - Hüsing, Paul

AU - Kohlmann, Sebastian

AU - Lehmann, Marco

AU - Shedden-Mora, Meike

AU - Toussaint, Anne

AU - Uhlenbusch, Natalie

AU - Weigel, Angelika

PY - 2022/3

Y1 - 2022/3

N2 - BACKGROUND: In 2013, the diagnosis of somatic symptom disorder (SSD) was introduced into the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). This review aims to comprehensively synthesize contemporary evidence related to SSD.METHODS: A scoping review was conducted using PubMed, PsycINFO, and Cochrane Library. The main inclusion criteria were SSD and publication in the English language between 01/2009 and 05/2020. Systematic search terms also included subheadings for the DSM-5 text sections; i.e., diagnostic features, prevalence, development and course, risk and prognostic factors, culture, gender, suicide risk, functional consequences, differential diagnosis, and comorbidity.RESULTS: Eight hundred and eighty-two articles were identified, of which 59 full texts were included for analysis. Empirical evidence supports the reliability, validity, and clinical utility of SSD diagnostic criteria, but the further specification of the psychological SSD B-criteria criteria seems necessary. General population studies using self-report questionnaires reported mean frequencies for SSD of 12.9% [95% confidence interval (CI) 12.5-13.3%], while prevalence studies based on criterion standard interviews are lacking. SSD was associated with increased functional impairment, decreased quality of life, and high comorbidity with anxiety and depressive disorders. Relevant research gaps remain regarding developmental aspects, risk and prognostic factors, suicide risk as well as culture- and gender-associated issues.CONCLUSIONS: Strengths of the SSD diagnosis are its good reliability, validity, and clinical utility, which substantially improved on its predecessors. SSD characterizes a specific patient population that is significantly impaired both physically and psychologically. However, substantial research gaps exist, e.g., regarding SSD prevalence assessed with criterion standard diagnostic interviews.

AB - BACKGROUND: In 2013, the diagnosis of somatic symptom disorder (SSD) was introduced into the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). This review aims to comprehensively synthesize contemporary evidence related to SSD.METHODS: A scoping review was conducted using PubMed, PsycINFO, and Cochrane Library. The main inclusion criteria were SSD and publication in the English language between 01/2009 and 05/2020. Systematic search terms also included subheadings for the DSM-5 text sections; i.e., diagnostic features, prevalence, development and course, risk and prognostic factors, culture, gender, suicide risk, functional consequences, differential diagnosis, and comorbidity.RESULTS: Eight hundred and eighty-two articles were identified, of which 59 full texts were included for analysis. Empirical evidence supports the reliability, validity, and clinical utility of SSD diagnostic criteria, but the further specification of the psychological SSD B-criteria criteria seems necessary. General population studies using self-report questionnaires reported mean frequencies for SSD of 12.9% [95% confidence interval (CI) 12.5-13.3%], while prevalence studies based on criterion standard interviews are lacking. SSD was associated with increased functional impairment, decreased quality of life, and high comorbidity with anxiety and depressive disorders. Relevant research gaps remain regarding developmental aspects, risk and prognostic factors, suicide risk as well as culture- and gender-associated issues.CONCLUSIONS: Strengths of the SSD diagnosis are its good reliability, validity, and clinical utility, which substantially improved on its predecessors. SSD characterizes a specific patient population that is significantly impaired both physically and psychologically. However, substantial research gaps exist, e.g., regarding SSD prevalence assessed with criterion standard diagnostic interviews.

U2 - 10.1017/S0033291721004177

DO - 10.1017/S0033291721004177

M3 - SCORING: Review article

C2 - 34776017

VL - 52

SP - 632

EP - 648

JO - PSYCHOL MED

JF - PSYCHOL MED

SN - 0033-2917

IS - 4

ER -